Literature DB >> 30551432

Molecular modulators of celastrol as the keystones for its diverse pharmacological activities.

Sin Wi Ng1, Yinghan Chan1, Dinesh Kumar Chellappan2, Thiagarajan Madheswaran3, Farrukh Zeeshan3, Yik Lung Chan4, Trudi Collet5, Gaurav Gupta6, Brian G Oliver4, Peter Wark7, Nicole Hansbro7, Alan Hsu7, Philip Michael Hansbro8, Kamal Dua9, Jithendra Panneerselvam3.   

Abstract

In the recent years, much attention has been focused on identifying bioactive compounds from medicinal plants that could be employed in therapeutics, which is attributed to their potent pharmacological actions and better toxicological profile. One such example that has come into the light with considerable interest is the pentacyclic triterpenoid, celastrol, which has been found to provide substantial therapeutic properties in a variety of diseases. In an effort to further accelerate its potential to be utilized in clinical practice in the future; along with advancing technologies in the field of drug discovery and development, different researchers have been investigating on the various mechanisms and immunological targets of celastrol that underlie its broad spectrum of pharmacological properties. In this review, we have collated the various research findings related to the molecular modulators responsible for different pharmacological activities shown by celastrol. Our review will be of interest to the herbal, biological, molecular scientist and by providing a quick snapshot about celastrol giving a new direction in the area of herbal drug discovery and development.
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Anti-cancer; Anti-diabetic; Anti-inflammatory; Anti-obesity; Celastrol; Molecular modulators; Neuroprotective

Mesh:

Substances:

Year:  2018        PMID: 30551432     DOI: 10.1016/j.biopha.2018.11.051

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  19 in total

1.  Celastrol inhibits pathologic neovascularization in oxygen-induced retinopathy by targeting the miR-17-5p/HIF-1α/VEGF pathway.

Authors:  Kun Zhao; Yaping Jiang; Jing Zhang; Jing Shi; Pengxiang Zheng; Chuanxi Yang; Yihui Chen
Journal:  Cell Cycle       Date:  2022-06-13       Impact factor: 5.173

2.  Celastrol inhibits the proliferation and migration of MCF-7 cells through the leptin-triggered PI3K/AKT pathway.

Authors:  Pingping Chen; Bin Wang; Meng Li; Chunxue Cui; Fei Liu; Yonggang Gao
Journal:  Comput Struct Biotechnol J       Date:  2022-06-20       Impact factor: 6.155

Review 3.  Natural Bioactive Compounds as Potential Browning Agents in White Adipose Tissue.

Authors:  Youngshim Choi; Liqing Yu
Journal:  Pharm Res       Date:  2021-03-30       Impact factor: 4.200

4.  Early Celastrol Administration Prevents Ketamine-Induced Psychotic-Like Behavioral Dysfunctions, Oxidative Stress and IL-10 Reduction in The Cerebellum of Adult Mice.

Authors:  Stefania Schiavone; Paolo Tucci; Luigia Trabace; Maria Grazia Morgese
Journal:  Molecules       Date:  2019-11-05       Impact factor: 4.411

5.  Celastrol regulates bone marrow mesenchymal stem cell fate and bone-fat balance in osteoporosis and skeletal aging by inducing PGC-1α signaling.

Authors:  Li Li; Bing Wang; Yawei Li; Lei Li; Yuliang Dai; Guohua Lv; Pengfei Wu; Pengzhi Li
Journal:  Aging (Albany NY)       Date:  2020-07-28       Impact factor: 5.682

6.  Design, Synthesis and In Vitro Investigation of Novel Basic Celastrol Carboxamides as Bio-Inspired Leishmanicidal Agents Endowed with Inhibitory Activity against Leishmania Hsp90.

Authors:  Ivan Bassanini; Silvia Parapini; Erica E Ferrandi; Elena Gabriele; Nicoletta Basilico; Donatella Taramelli; Anna Sparatore
Journal:  Biomolecules       Date:  2021-01-05

7.  Celastrol Self-Stabilized Nanoparticles for Effective Treatment of Melanoma.

Authors:  Jinran Li; Yuxi Jia; Peng Zhang; Huailin Yang; Xianling Cong; Lin An; Chunsheng Xiao
Journal:  Int J Nanomedicine       Date:  2020-02-19

8.  Hyaluronic acid-functionalized bilosomes for targeted delivery of tripterine to inflamed area with enhancive therapy on arthritis.

Authors:  Hailing Yang; Zhenjie Liu; Yonglong Song; Changjiang Hu
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

9.  Identification of Putative Non-Substrate-Based XT-I Inhibitors by Natural Product Library Screening.

Authors:  Thanh-Diep Ly; Anika Kleine; Bastian Fischer; Vanessa Schmidt; Doris Hendig; Joachim Kuhn; Cornelius Knabbe; Isabel Faust
Journal:  Biomolecules       Date:  2020-10-21

Review 10.  Multiple Myeloma Inhibitory Activity of Plant Natural Products.

Authors:  Karin Jöhrer; Serhat Sezai Ҫiҫek
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.